US HB4769 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on October 21 2019 - 25% progression, died in committee
Action: 2019-10-22 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on October 21 2019 - 25% progression, died in committee
Action: 2019-10-22 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires the Centers for Medicare & Medicaid Services (CMS) to establish at least one prescription drug plan that is operated by Medicare. Among other things, the plan must (1) serve the entire United States; and (2) be the default plan for enrollees under the Medicare prescription drug benefit, unless the enrollee chooses another plan. Additionally, the CMS must negotiate prices for prescription drugs that are covered under the plan and, if appropriate, encourage the use of more affordable therapeutic equivalents. (Currently, the CMS is prohibited from negotiating the prices of covered drugs under the Medicare prescription drug benefit.) The Agency for Healthcare Research and Quality must assess the clinical benefits of drugs and make recommendations to the CMS regarding price negotiations, based on specified information (e.g., comparable international prices).
Title
Medicare Prescription Drug Savings and Choice Act of 2019
Sponsors
Rep. Janice Schakowsky [D-IL] |
History
Date | Chamber | Action |
---|---|---|
2019-10-22 | House | Referred to the Subcommittee on Health. |
2019-10-21 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2019-10-21 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2019-10-21 | House | Introduced in House |
Same As/Similar To
SB2650 (Same As) 2019-10-21 - Read twice and referred to the Committee on Finance. (text: CR S5924-5925)
Subjects
Administrative remedies
Advisory bodies
Department of Health and Human Services
Health
Medicare
Prescription drugs
Public contracts and procurement
Advisory bodies
Department of Health and Human Services
Health
Medicare
Prescription drugs
Public contracts and procurement
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/4769/all-info |
Text | https://www.congress.gov/116/bills/hr4769/BILLS-116hr4769ih.pdf |